These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7509513)

  • 1. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors.
    Turini ME; Gaudette DC; Holub BJ; Kirkland JB
    Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.
    Nakano T; Hanasaki K; Arita H
    Thromb Res; 1989 Oct; 56(2):299-306. PubMed ID: 2617470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galpha12 and galpha13 are phosphorylated during platelet activation.
    Offermanns S; Hu YH; Simon MI
    J Biol Chem; 1996 Oct; 271(42):26044-8. PubMed ID: 8824244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
    Cho HJ; Cho JY; Rhee MH; Lim CR; Park HJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1677-82. PubMed ID: 17331333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
    Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
    J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
    Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
    J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
    Nguyen BL; Saitoh M; Ware JA
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.
    Yang Y; Wang X; Zhang L; An H; Zao Z
    Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of platelet aggregation from the Cyanophyceae Oscillatoria rosea (NIES-208).
    Rho MC; Matsunaga K; Yasuda K; Ohizumi Y
    Planta Med; 1996 Oct; 62(5):473-4. PubMed ID: 8923815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ; Leis LA; Dunlop PC
    J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role for extracellular bicarbonate in U-46619-induced rat platelet aggregation.
    Yokoyama K; Kudo I; Nakamura H; Inoue K
    Thromb Res; 1994 May; 74(4):369-76. PubMed ID: 8085238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain-induced down-regulation of protein kinase C inhibits dense-granule secretion in human platelets. Inhibition of platelet aggregation or calpain activity preserves protein kinase C and restores full secretion.
    Patel Y; Kakkar VV; Authi KS
    Biochim Biophys Acta; 1994 Dec; 1224(3):480-8. PubMed ID: 7803507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.